Investor mix

Share of named investors · each counted once

Investor type

71%

Investment firms

57%

24%

Corporate investors

36%

0%

Family offices

7%

6%

Sovereign funds

0%

Headquarters

59%

North America

36%

24%

Europe

43%

18%

Asia & Middle East

14%

0%

Oceania

7%

Investor names recorded for 5/7 rounds at Moderna and 5/5 at BioNTech